The early recognition and treatment of amyloidosis in order to minimise the effects of decline in health. Our focus is therefore on the improvement of diagnosis and the treatment of patients with amyloidosis. In addition, we offer information to patients, physicians and other individuals involved.
Who we are
The Groningen Amyloidosis Center of Expertise is a collaboration of various disciplines at the University Medical Center Groningen, engaged in diagnosis and treatment of systemic and localised amyloidosis. The department of Internal Medicine has a coordinating role.
|3rd Multidisciplinary Symposium Systemic Amyloidosis 2021|| On Thursday 11 November 2021, the 3rd Multidisciplinary Symposium Systemic Amyloidosis will be organized at Van der Valk, Houten, The Netherlands.
For further information see Doen-Congressen.
|How do we deal with the corona virus at the UMCG (COVID-19)?||On this page you will find all information about how we deal with the corona virus at the UMCG (COVID-19)|
|The International Society of Amyloidosis (ISA) has given recommendations for the management of amyloidosis patients during the COVID-19 pandemic||View the latest version here (April 20, 2020)|
|Stichting Amyloïdose Nederland (SAN)||View the presentations held on the patient meeting day of March13, 2021.|
|Expertisenetwerk Amyloïdose||December 2019 on-line|